翻訳と辞書
Words near each other
・ Hepatology
・ Hepatology (journal)
・ Hepatoma-derived growth factor
・ Hepatomegaly
・ Hepatopancreas
・ Hepatophrenic ligament
・ Hepatoportoenterostomy
・ Hepatoporus
・ Hepatoprotection
・ Hepatopulmonary syndrome
・ Hepatorenal ligament
・ Hepatorenal recess of subhepatic space
・ Hepatorenal syndrome
・ Hepatosplenic T-cell lymphoma
・ Hepatosplenomegaly
Hepatotoxicity
・ Hepatotoxin
・ Hepatozoon
・ Hepatus
・ Hepatus epheliticus
・ Hepatyrix
・ Hepberg
・ Hepburn
・ Hepburn (band)
・ Hepburn (surname)
・ Hepburn Act
・ Hepburn Avenue
・ Hepburn Heights bushland
・ Hepburn Island
・ Hepburn Library


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Hepatotoxicity : ウィキペディア英語版
Hepatotoxicity

Hepatotoxicity (from ''hepatic toxicity'') implies chemical-driven liver damage.
The liver plays a central role in transforming and clearing chemicals and is susceptible to the toxicity from these agents. Certain medicinal agents, when taken in overdoses and sometimes even when introduced within therapeutic ranges, may injure the organ. Other chemical agents, such as those used in laboratories and industries, natural chemicals (e.g., microcystins) and herbal remedies can also induce hepatotoxicity. Chemicals that cause liver injury are called hepatotoxins.
More than 900 drugs have been implicated in causing liver injury and it is the most common reason for a drug to be withdrawn from the market. Hepatotoxicity and drug-induced liver injury also account for a substantial number of compound failures, highlighting the need for drug screening assays, such as stem cell-derived hepatocyte-like cells, that are capable of detecting toxicity early in the drug development process. Chemicals often cause subclinical injury to the liver, which manifests only as abnormal liver enzyme tests. Drug-induced liver injury is responsible for 5% of all hospital admissions and 50% of all acute liver failures.
== Cause ==

Adverse drug reactions are classified as type A (intrinsic or pharmacological) or type B (idiosyncratic). Type A drug reaction accounts for 80% of all toxicities.
Drugs or toxins that have a pharmacological (type A) hepatotoxicity are those that have ''predictable'' dose-response curves (higher concentrations cause more liver damage) and well characterized mechanisms of toxicity, such as directly damaging liver tissue or blocking a metabolic process. As in the case of acetaminophen overdose, this type of injury occurs shortly after some threshold for toxicity is reached.
Idiosyncratic (type B) injury occurs without warning, when agents cause ''non-predictable'' hepatotoxicity in susceptible individuals, which is not related to dose and has a variable latency period. This type of injury does not have a clear dose-response nor temporal relationship, and most often does not have predictive models. Idiosyncratic hepatotoxicity has led to the withdrawal of several drugs from market even after rigorous clinical testing as part of the FDA approval process; Troglitazone (Rezulin) and trovafloxacin (Trovan) are two prime examples of idiosyncratic hepatotoxins pulled from market.
When used orally, ketoconazole has been associated with hepatic toxicity, including some fatalities.

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Hepatotoxicity」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.